NCT07407725 Clinical Outcome Assessment for AT & BCI
| NCT ID | NCT07407725 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shirley Ryan AbilityLab |
| Condition | Spinal Cord Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-08 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-08 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many individuals with severe motor impairments rely on Assistive Technologies (ATs) or Brain-Computer Interfaces (BCIs) to interact with digital devices such as their computers. Clinicians and researchers currently lack a common framework to objectively quantify how much a given AT or BCI improves real-world function or to compare across tools. This project seeks to address this gap by developing a standardized method to objectively assess or compare the functional benefit of these tools on digital independence, i.e., the ability to independently operate computers, phones, and other digital systems, by creating a unique Digital Assessment Interface (DAI). This assessment will be a simulation of online and digital activities that prior work has determined is important to functional daily living in the digital domain. Participants will complete this assessment with various ATs and BCIs, and these scores will be used to create an index, which will be comprised of performance outcomes, clinician-reported outcomes, and patient-reported outcomes. The tool aims to quantify and compare digital task performance across devices and user populations. The primary objective of this study is to develop an index. The index will quantify functional performance of individuals using various ATs and BCIs. The secondary objectives are to extensively evaluate the psychometric properties of the index, such as the validity, responsiveness, reliability, and floor/ceiling effects both globally and across different devices and impairment levels, ensuring that it can reliably measure the impact of an AT or BCI on a user's ability to independently operate digital systems; and to characterize the familiarization and use of specific BCI and AT systems with reference to a normative healthy control population.
Eligibility Criteria
Enrollment will involve three different cohorts, namely a cohort of healthy participant, a cohort of ALS/SCI participant who underwent the implant of an invasive BCI device, and a cohort of ALS/SCI participants without any implanted BCI device. Below are listed the inclusion and exclusion criteria for each diagnostic group. Spinal Cord Injury (SCI): Inclusion Criteria: * Age at or above 18 years old; * Diagnosis of spinal cord injury, at the level of T1 or above levels (between C1 and T1); * Ability to communicate independently or with a support device, or with a legal representative; * Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed. Exclusion Criteria: * Participation in another trial that would conflict with the current study or clinical endpoint interference may occur. Amyotrophic Lateral Sclerosis (ALS): Inclusion criteria: * Age at or above 18 years old; * Diagnosis of amyotrophic lateral sclerosis; * Ability to communicate independently, with a support device, or with a legal representative; * Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed. Exclusion criteria: ● Participation in another trial that would conflict with the current study or clinical endpoint interference may occur. Healthy Controls: Inclusion criteria: * Age at or above 18 years old; * No history of neurological or psychiatric disorders; * Ability to provide written informed consent; * Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed. Exclusion criteria: * Participation in another trial that would conflict with the current study or clinical endpoint interference may occur; * Cognitive, visual, or auditory deficits that would interfere with study participation; * Current or prior diagnosis or condition that could confound study assessments.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07407725 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07407725 currently recruiting?
Yes, NCT07407725 is actively recruiting participants. Contact the research team at ajayaraman@sralab.org for enrollment information.
Where is the NCT07407725 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07407725 clinical trial?
NCT07407725 is sponsored by Shirley Ryan AbilityLab. The trial plans to enroll 60 participants.